HALUK YUZUGULLU

Citeras av

	Alla	Sedan 2016
Citat	1919	1593
h-index	12	11
i10-index	12	12

380

190

285

20092010201120122013201420152016201720182019202020216 17 29 40 46 58 107 223 263 303 364 370 69

Medförfattare

Mehmet OzturkIzmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, TurkeyVerifierad e-postadress på deu.edu.tr
Serif SenturkResearch Group Leader at Izmir Biomedicine and Genome CenterVerifierad e-postadress på ibg.edu.tr
Ozge gursoy YuzugulluDana Farber Cancer Institute, Harvard Medical SchoolVerifierad e-postadress på dfci.harvard.edu
Nuri OzturkProfessor @ Gebze Technical UniversityVerifierad e-postadress på gtu.edu.tr
Ayça Arslan ErgülUNAM, Bilkent UniversityVerifierad e-postadress på bilkent.edu.tr
Adam C PalmerAssistant Professor, UNC-Chapel HillVerifierad e-postadress på unc.edu
Wei LiChildren's National Hospital, George Washington UniversityVerifierad e-postadress på childrensnational.org
Nathanael GrayProfessor of Biological Chemistry and Molecular Pharmacology, Harvard Medical SchoolVerifierad e-postadress på dfci.harvard.edu
Richard YoungProfessor of Biology, MITVerifierad e-postadress på wi.mit.edu
Daniel G. StoverOhio State University Comprehensive Cancer CenterVerifierad e-postadress på osumc.edu
Ziao LinPhD candidate, Harvard UniversityVerifierad e-postadress på g.harvard.edu
Nese AtabeyIzmir Biomedicine&Genome Center (IBG)Verifierad e-postadress på ibg.edu.tr
Kira GritsmanAlbert Einstein College of MedicineVerifierad e-postadress på einsteinmed.org
Hilal Ozdag PhDAnkara University Biotechnology InstituteVerifierad e-postadress på ankara.edu.tr
Rengul Cetin AtalayUniversity of Chicago and Middle East Technical UniversityVerifierad e-postadress på metu.edu.tr
Cigdem Ozen, Ph.D.Specialist at Izmir International Biomedicine and Genome Institute, iBG-izmir, Dokuz EylülVerifierad e-postadress på deu.edu.tr
Gokhan YildizKaradeniz Technical University School of Medicine Department of Medical BiologyVerifierad e-postadress på ktu.edu.tr
biter bilenPostdoctoral fellowVerifierad e-postadress på stanford.edu
Bala Gur DedeogluAnkara University Biotechnology InstituteVerifierad e-postadress på ankara.edu.tr
Isik G. YulugAssociate Professor of Molecular Biology and Genetics, Bilkent UniversityVerifierad e-postadress på fen.bilkent.edu.tr

HALUK YUZUGULLU

Astrazeneca Pharmaceuticals

Verifierad e-postadress på astrazeneca.com

cancer stem cells breast cancer PDX leukemia liver cancer colorectal carcinoma


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting HYJJZ Lauren M. Thorpe Nature Reviews Cancer 15 (1), 7–24, 2014	831*	2014
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors JJZ Shom Goel, Qi Wang, April C. Watt, Sara M. Tolaney, Deborah A. Dillon ... Cancer Cell 29 (3), p255–269, 2016	240	2016
CDK7-dependent transcriptional addiction in triple-negative breast cancer Y Wang, T Zhang, N Kwiatkowski, BJ Abraham, TI Lee, S Xie, H Yuzugullu, ... Cell 163 (1), 174-186, 2015	236	2015
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik, A Toylu, N Tasdemir, ... Molecular cancer 8 (1), 1-20, 2009	227	2009
Senescence and immortality in hepatocellular carcinoma M Ozturk, A Arslan-Ergul, S Bagislar, S Senturk, H Yuzugullu Cancer letters 286 (1), 103-113, 2009	93	2009
Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation O Gursoy‐Yuzugullu, H Yuzugullu, M Yilmaz, M Ozturk Liver International 31 (4), 561-571, 2011	67	2011
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers. SP Hydbring P, Wang Y, Fassl A, Li X, Matia V, Otto T, Choi YJ, Sweeney KE ... Cancer Cell 31 (4), 576–590, 2017	59	2017
Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α K Gritsman, H Yuzugullu, T Von, H Yan, L Clayton, C Fritsch, SM Maira, ... The Journal of clinical investigation 124 (4), 1794-1809, 2014	51	2014
Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis G Yildiz, A Arslan-Ergul, S Bagislar, O Konu, H Yuzugullu, ... PloS one 8 (5), e64016, 2013	47	2013
A PI3K p110β–Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis H Yuzugullu, L Baitsch, T Von, A Steiner, H Tong, J Ni, LK Clayton, ... Nature communications 6 (1), 1-13, 2015	33	2015
The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity M Mumcuoglu, S Bagislar, H Yuzugullu, H Alotaibi, S Senturk, ... PloS one 5 (6), e11288, 2010	22	2010
NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K–AKT and JAK–STAT3 pathways H Yuzugullu, T Von, LM Thorpe, SR Walker, TM Roberts, DA Frank, ... Cell discovery 2 (1), 1-13, 2016	13	2016
Development of a second-generation TRAIL agonist and predictive biomarker profile for colorectal cancer S Ghassemifar, Y Hashambhoy-Ramsay, H Yuzugullu, T Utermark, ... Cancer Research 79 (13), 2019		2019
Methods for selecting and treating patients with a trail-based therapeutic or death receptor agonist D Tamara, S Ghassemifar, Y Hashambhoy-ramsay, DHC MARCANTONIO, ... US Patent App. 16/305,289, 2019		2019
INVESTIGATION OF CAUSATIVE AGENTS IN COMMUNITY-ACQUIRED ATYPICAL PNEUMONIA CASES E ÇALIŞKAN, Ş ÖKSÜZ, C ÖZTÜRK, I Sahin, O Kilincel, N Akar, ...		2019
MM-161, a first-in-class pan-FGFR antibody T Dake, G Finn, M Geddie, N Kohli, M Razlog, L Xu, V Paragas, ... Cancer Research 77 (13 Supplement), 22-22, 2017		2017
Targeted Therapy for Hepatocellular Carcinoma: What`s New? H Yuzugullu, O Gursoy-Yuzugullu Liver Res Open J 1 (1), e1-e3, 2015		2015
PI3K-p110β is required for leukemic transformation and HSC depletion in the absence of Pten H Yuzugullu, L Baitsch, A Steiner, LK Clayton, K Gritsman, JJ Zhao Cancer Research 74 (19 Supplement), 4775-4775, 2014		2014
Genome-Wide Transcriptional Reorganization Associated with Senescence-to G Yildiz, A Arslan-Ergul, S Bagislar, O Konu, H Yuzugullu		2013
Doxorubicin-induced senescence in hepatocellular carcinoma cells O Gursoy-Yuzugullu, H Yuzugullu, M Ozturk Cancer Research 70 (8 Supplement), 3220-3220, 2010		2010

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Ladda upp PDF

Följ den här författaren

Citeras av

Medförfattare